Abstract:<p>Diffuse large B‐cell lymphoma (DLBCL) is the most common type of non‐Hodgkin's lymphoma, constituting biologically heterogeneous entities. Standard first line therapies cure ~60% of patients, the rest being either refractory or experiencing relapse. Currently, there are no robust predictive biomarkers of therapeutic response. Heterogeneity of DLBCL is partly explained by the cell of origin (COO), i.e. germinal center B cell (GCB) or activated B cell (ABC), with the latter exhibiting worse prognosis. While gene expression profiling (GEP) is the gold standard for determining COO, surrogate immunohistochemical algorithms are used clinically, but show significant discordance with GEP. Recently, additional subgroups with different prognoses have been reported. However, the tools/expertise required for analysis prohibit widespread deployment. Liquid biopsy‐based assays show promise in providing clinically actionable information, are non‐invasive and facilitate serial sampling to assess mechanisms of therapy resistance. Circulating, cell free DNA analysis has shown enhanced sensitivity, however, this modality cannot provide information on signaling pathways. Exosomes are endosomally derived vesicles, are found in high abundance in body fluids, and readily isolated using a variety of methods. Tumor derived exosomes contain genetic information and can reveal details for diagnostic, prognostic and therapeutic purposes in DLBCL. At present, standardized techniques for isolating exosomes are lacking and discriminating exosomes from neoplastic or normal B cells is challenging. Refinements in isolation procedures are required to realize their full potential as precision medicine tools to provide comprehensive information on disease subtypes, identify prognostic factors, allow real time monitoring of therapy response and to delineate drug targets.</p>

Critical Role of Extracellular Vesicles in Diffuse Large B-Cell Lymphoma; Pathogenesis, Potential Biomarkers, and Targeted Therapy—A Narrative Review

Extracellular Vesicles in Chronic Lymphocytic Leukemia: Tumor Microenvironment Messengers as a Basis for New Targeted Therapies?

The Roles of Exosomal microRNAs in Diffuse Large B-Cell Lymphoma: Diagnosis, Prognosis, Clinical Application, and Biomolecular Mechanisms

The Emerging Roles of Extracellular Vesicles As Communication Vehicles within the Tumor Microenvironment and Beyond

MicroRNA Expression in Exosome Extracellular Vesicles as Targets for Personalized Medicine in Diffuse Large B Cell Lymphoma Patients with HIV Infection

The Lymphatic Vascular System in Extracellular Vesicle-Mediated Tumor Progression

Extracellular vesicles: A dive into their role in the tumor microenvironment and cancer progression

Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival

Extracellular vesicles in the Chronic Myeloid Leukemia scenario: an update about the shuttling of disease markers and therapeutic molecules

Unraveling the Immune Microenvironment in Diffuse Large B-Cell Lymphoma: Prognostic and Potential Therapeutic Implications

Extracellular Vesicles in Breast Cancer: From Intercellular Communication to Therapeutic Opportunities

Exosomes and extracellular vesicles as liquid biopsy biomarkers in diffuse large B‐cell lymphoma: Current state of the art and unmet clinical needs

Extracellular vesicles in the tumor microenvironment: Therapeutic resistance, clinical biomarkers, and targeting strategies

Extracellular vesicles derived from immune cells: Role in tumor therapy

Extracellular Vesicles for Drug Delivery in Cancer Treatment

Analysis of CD20 and PD-L1 levels on small extracellular vesicles (sEV) produced by DLBCL cells and EBV-transformed B cells, and potential role in T cell inhibition

Universal extracellular vesicles and PD-L1+ extracellular vesicles detected by single molecule array technology as circulating biomarkers for diffuse large B cell lymphoma

Extracellular Vesicles and Their Applications in Tumor Diagnostics and Immunotherapy

Extracellular Vesicles: The Landscape in the Progression, Diagnosis, and Treatment of Triple-Negative Breast Cancer

Extracellular Vesicles: A New Perspective in Tumor Therapy

Extracellular Vesicles in Breast Cancer: From Biology and Function to Clinical Diagnosis and Therapeutic Management